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Abstract: Parkinson's disease (PD) is a neurodegenerative disorder due to dopamine deficit in substatia nigra. PD 
is mainly a sporadic disease with unestablished etiology. However, exposure to environmental toxins, head trauma, 
inflammation, and free radicals are potential reasons. Recently, the role of oxidative stress in neurological abnor-
malities, including PD, has been particularly addressed. Antioxidant remedies, particularly herbal antioxidants, 
have revealed new perspectives of research and therapy as possible preventive and therapeutic approaches for PD. 
In this paper, we reviewed the recently published papers on the effects of herbal medicines on PD alongside the 
pathogenesis of PD with regard to oxidative stress.  
Keywords: Antioxidant, Degenerative disorder, Herbal medicines, Medicinal plants, Oxidative stress, Parkinson's 
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INTRODUCTION 
 Parkinson’s disease (PD) is the second most common neurode-
generative disorder which is caused by reduction in dopamine level 
and loss of projecting dopaminergic neurons in striatum and sub-
stantia nigra [1]. Dopaminergic impairment in PD leads to altera-
tions in basal glutamatergic synaptic transmission of striatum and 
plasticity in the medium spiny neurons [1]. PD affects 2% of the 
population older than 65 years, with 7-10 million individuals af-
fected worldwide [2]. Its symptoms include resting tremor, rigidity 
of muscles, bradykinesia, and postural and gait impairments [3].  
 The most cases of Parkinson’s disease are sporadic, with unde-
termined etiology. . However, exposure to environmental toxins, 
head trauma, inflammation, and free radicals are potential reasons 
[4, 5]. Remarkable neuroinammation which is exacerbated by free 
radicals has been reported in the substantia nigra in the patients 
with PD [6]. The neurotoxins and cytokines released from the reac-
tive inammatory cells cause distraction of the projecting dopa-
minergic neurons in striatum and substantia nigra [6]. Neu-
roinammation inhibition in the striatum and substantia nigra has 
been shown to signicantly ameliorate the behavioral deciency in 
PD [7]. 
 Recently, special attention has been paid to the role of oxidative 
stress in neurological abnormalities, including PD. In fact, exces-
sive production of reactive oxidative species (ROS) has been con-
sidered as the cause of neuronal death [8, 9]. 
 There is no cure for PD yet, and treatment is mainly sympto-
matic. The therapies based on a dopamine replacement consist of 
the use of dopamine precursors; however, substantial adverse 
eects may appear in long-term usage. Novel pharmacotherapy and 
cell replacement, before being routinely used in humans, need ex-
tensive evaluation [10].  
 The evidence that mitochondria and ROS as the main neurode-
generation players have caused antioxidant remedies opens new 
perspectives of research and therapy as possible preventive and 
therapeutic approaches for PD [11].  
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 In fact, PD usually starts long before its manifestations appear. 
Therefore, the diets and medicinal plants with low side effects to 
prevent them as well as knowledge of the first appearing biomark-
ers and diagnostic methods to disguise the progressing disease at 
early stages are important. Medicinal plants with antioxidant ac-
tivities, which are effective on PD have been recently reviewed 
[12]. However, this review article only covers the Indian plants. 
In this paper, we reviewed the recently published papers on the 
effects of herbal medicines on PD alongside the pathogenesis of PD 
with regard to oxidative stress.  
PATHOGENESIS OF PD 
 About 50 years ago the dopaminergic defect was suggested as 
the main neurochemical cause of PD; however, the exact causes of 
this disease are not clear. About 10% of the patients with PD are 
estimated to have mutations in selected genes. However, it has fur-
ther complicated the general picture about the underlying factors of 
PD [13].  
 In PD, there is a loss of dopaminergic neurons in substantia 
nigra with projecting nerve fibers residing in the striatum. These 
neurons play a crucial role in control of voluntary movements, and 
their degeneration usually leads to debilitating symptoms including 
resting tremor, muscular rigidity, postural imbalance, and bradyki-
nesia. Aging is an important variable associated with the onset of 
PD. So that, deficits in the normal cellular function that usually 
occur with aging increase the vulnerability of dopaminergic neu-
rons [14]. 
 There is no single causative factor to identify sporadic PD. In 
fact, a multi-factorial nature contributes to the process of nigral cell 
death, of which mitochondrial dysfunction and elevated levels in 
formation of ROS are the most important mechanisms [15]. An-
other factor which may contribute to the neuronal loss underlying 
PD is neuro-inflammation which in turn increases the ROS and 
exacerbates PD. The inflammatory response associated with the cell 
loss in the dopaminergic nigrostriatal tract and the role of immune 
mechanisms, which are associated with oxidative stress, are being 
increasingly addressed as important factors in the pathogenesis of 
PD [13]. 
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The Role of Free Radicals in PD 
 Although familial forms of PD have been described, ROS is 
likely the main underlying mechanism in both genetic and idio-
pathic cases of PD, leading to cellular dysfunction of dopaminergic 
neurons. In this regard, the substantia nigra of PD patients contains 
higher levels of oxidized lipids, DNA and proteins as well as lower 
levels of glutathione (GSH) [16].  
 Oxidative stress is potential when there is an imbalance be-
tween ROS production and cellular antioxidant activity [17, 18]. 
The major sources of ROS which cause oxidative stress and deficit 
in nigral dopaminergic neurons seem to be mitochondrial dysfunc-
tion, neuroinflammation and dopamine metabolism [8].  
 Mitochondria are the main cellular source of free radicals and 
have a crucial role in oxidative phosphorylation and electron trans-
port [19]. Mitochondria are also involved in calcium homeostasis 
and regulation and instigation of cell-death pathways. Hence, there 
is a complex interaction between mitochondria function and other 
parts of cellular machinery which affects cell survival. Notably, 
mitochondrial dysfunction is not detected in all patients with PD. 
However, this factor may have a critical contribution in the future 
treatment [20]. 
 Opening of the mitochondrial permeability transition pore is a 
process which usually occurs under oxidative stress, leading to 
collapse of the mitochondrial membrane potential. Oxidative stress 
and mitochondrial dysfunction cause activation of apoptotic path-
ways in response to pro-apoptotic molecules. Mitochondrial dys-
function causes impairment of energy metabolism which in turn 
renders the cells vulnerable to ‘excitotoxicity’. This excitotoxicity 
increases ROS generation which in turn increases cellular injury 
[8]. Mitochondrial dysfunction through increasing oxidative stress 
induces damage to lipids, DNA and proteins and decreases the lev-
els of intrinsic antioxidants [16].  
 Higher plasma level of 8-hydroxydeoxyguanosine has been 
reported in patients with PD than in controls. More importantly, 
increased serum uric acid level, which is a potent antioxidant, is 
associated with a lower risk of PD [21]. 
THE ROLE OF DOPAMINE IN INDUCTION OF OXIDATIVE 
STRESS 
 Although the symptoms of PD can be controlled by drugs such 
as levodipa, the benefits of these drugs usually diminish or become 
less consistent over time. Levodopa is the most effective 
medication for PD. It passes into the brain and is converted to 
dopamine. Levodopa is usually used in combination with carbidopa 
or benserazide which reduce the metabolism of levodopa outside 
the brain [22].  
 As already mentioned, the oxidative stress is one of the main 
causes of cellular dysfunction and PD patients have high levels of 
oxidized lipids, proteins and DNA in their substantia nigra, as well 
as low level of reduced GSH. Due to the presence of ROS-gene-
rating enzymes like monoamine oxidase and tyrosine hydroxylase, 
the dopaminergic neurons are prone to oxidative stress. The major 
sources of this oxidative stress are dopamine quinone which is 
produced during dopamine metabolism. In this regard, excess 
cytosolic dopamine is readily oxidized, producing dopamine 
quinone. Dopamine quinone is able to modify some of proteins 
such as DJ-1, UCH-L1 and -synuclein whose dysfunctions have 
been shown to be associated with dopamine pathophysiology. -
Synuclein permeabilizes the vesicle membrane, causing leakage of 
dopamine into the cytosol, which inducesdopamine quinone gene-
ration [16]. Moreover, dopamine quinone-modified -synuclein is 
able to inhibit normal degradation of other proteins. Furthermore, 
dopamine quinone species are able to modify the cellular molecules 
such as protein cysteinyl residues and GSH with normal functions 
being crucial for cell survival. Dopamine quinone induces the 
conversion of -synuclein to cytotoxic form, as well [23].  
 DJ-1 and UCH-L1 have a cysteine residue which is crucial for 
their activities. The oxidative modification of their cysteine has 
been reported in PD patients [24]. Dopamine quinone also can lead 
to dysfunction of mitochondria and inactivation of tyrosine 
hydroxyalase and dopamine transporter [16]. Furthermore, the 
proteins that assist in protein folding in endoplasmic reticulum, 
including protein disulfide isomerase-5 and ER-60/GRP58/ERp57, 
are also modified by dopamine quinine [22]. Dopamine quinone 
also induces proteasomal inhibition leading to apoptosis of the cells 
[25]. Moreover, dopamine quinone is able to cyclize and become 
the highly reactive aminochrome. In this form the redox-cycling 
can lead to depletion of cellular nicotinamide adenine dinucleotide 
phosphate  (NADPH) and generation of superoxide, and ultimately 
it may polymerize to form neuromelanin which exacerbates the 
neurodegenerative process by triggering neuro-inflammation [26]. 
Neuromelanin is one of the final products of dopamine oxidation 
and is accumulated in the nigral region. Furthermore, during 
dopamine metabolism by monoamine oxidase, hydrogen peroxide 
is also generated which is converted to the highly reactive hydroxyl 
radical in the presence of transition metal ions, inducing oxidative 
stress [16].  
 Dopamine has been shown to cause selective toxicity to 
dopaminergic terminals proportional to the levels of dopamine 
oxidation and quinone-modified proteins [27]. Cysteinyl-catechol 
derivatives also are found in higher than normal levels in 
postmortem nigral tissues of patients with PD, suggesting cytotoxic 
nature of dopamine oxidation [16].  
 The toxic nature of dopamine oxidation suggests that plant 
antioxidants may have preventive and/or curative effect on PD. 
ANTIOXIDANTS AS A TREATMENT STRATEGY OF PD 
 Coenzyme Q10 (CoQ10) is an antioxidant which acts as a potent 
electron transporter for mitochondrial complexes I and II. CoQ10 
levels are low in mitochondria of patients with PD. The ratio of 
oxidized CoQ10 to reduced one is higher in PD patients than in 
controls, representing higher oxidative stress in PD patients [28]. In 
a randomized placebo-controlled trial, high-dose of CoQ10 (1200 
mg/day) in conjunction with -tocopherol, was capable of slowing 
the progression of disease [29]. Large clinical trials are now being 
planned to investigate the potential effects of CoQ10 and other 
antioxidants as disease-modifying agents. Resveratrol which is a 
polyphenolic compound in grape skin with antioxidant activity 
induces expression of genes involved in oxidative phosphorylation 
and mitochondrial biogenesis. It is able to protect 1-methyl-4-
phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic 
neuron injury in mice [30]. 
 The strategies to counteract ROS and oxidative stress have been 
shown to be effective in most ROS-induced diseases such as cancer 
[31, 32], diabetes mellitus [33, 34], atherosclerosis [35, 36] and 
infectious diseases [37, 38], rather than PD and some other neuro-
logical diseases [39, 40]. Although there are some encouraging data 
suggesting that the compounds affecting mitochondrial function and 
antioxidant level may slow down PD progression, the data from 
human studies are not enough to arrive at a definite conclusion. In 
this regard, the results obtained from medicinal plants with antioxi-
dant activity are encouraging [41, 42]. 
MEDICINAL PLANTS AND THEIR BYPRODUCTS IN PD 
 Medicinal plants have recently attracted considerable attention 
due to prevention and treatment of various diseases including PD 
[42-44]. A lot of medicinal plants and their formulations have been 
investigated with regard to PD and can be an alternative for drug 
discovery. The plants and their components presented here are the 
most promising candidates for new formulations. 
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1. Acanthopanax senticosus 
 Acanthopanax senticosus is from the Araliaceae family. The 
ethanol extract of this plant has been shown to exert protective ef-
fect on dopaminergic neurons in rodent models of PD. It also in-
creases dopamine and noradrenaline levels in PD rat model [45]. 
Sesamin is one of A. senticosus components which modulates cata-
lase (CAT), superoxide dismutase (SOD), tyrosine hydroxylase 
(TH), inducible nitric oxide synthase (iNOS) and interleukin-6 ex-
pression in dopaminergic cells against oxidative stress induced by 
1-methyl-4-phenylpyridine (MPP) [46, 47].  
2. Alpinia oxyphylla 
 Alpinia oxyphylla Miq. is from Zingiberaceae family. Its dried, 
ripe seeds and ethanol extract protect against 6-OHDA-induced 
damage to dopaminergic neurons and PC12 cells in zebrafish [48]. 
Protocatechuic acid derived from A. oxyphylla is effective on PD in 
animal models. It also inhibits MPTP-induced neurotoxicity in mice 
and reduces sodium nitroprusside- or hydrogen peroxide-induced 
cell death in PC12 cells [49]. 
3. Astragalus membranaceus 
 Astragalus membranaceus var. mongholicus is from Legumino-
sae family. Astragaloside IV prepared from this plant prevents 
MPP+-induced SH-SY5Y cell death by inhibition of ROS produc-
tion. Astragaloside IV prevents 6-OHDA induced death of dopa-
minergic neurons in a dose-dependent manner [50]. Astragalus 
polysaccharides derived from this plant can prevent the toxicity of 
bendopa caused by free radicals produced by self-oxidation which 
could promote the development of PD [51]. 
4. Camellia sinensis  
 Green tea produced from the leaves of Camellia sinensis 
(Theaceae family) can reduce the risk of PD [52]. It also attenuates 
6-OHDA-induced cell death in SH-SY5Y cells. The green tea cate-
chins have also preventive effects on the SH-SY5Y cells and PD in 
rat model, via inhibition of ROS-nitrogen monoxide (NO) pathway 
[53]. The main components of catechins include ()epicatechin 
gallate, ()epigallocatechin-3-gallate, ()epigallocatechin, and 
()epicatechin, all of which catechins have protective activity on 
PC12 cells with the best effect by ()epicatechin gallate. ()Epigal-
locatechin-3-gallate has been shown, in dopaminergic SHSY-5Y 
cells, to reduce dichlorodiphenyl-trichloroethane-induced cell death 
and regulate dopamine transporter through protein kinase C in 
MPP+ induced PC12 cells [54]. ()Epigallocatechin-3-gallate is 
also able to inhibit cell death and iNOS expression in the MPTP-
induced mice model of PD [55, 56]. Notably, this plant in various 
studies has shown high antioxidant activity [57, 58]. 
5. Cassia obtusifolia, Cassiae semen or Cassia tora 
 Ethanol extract of Cassia obtusifolia, Cassiae semen or Cassia 
tora L. (Leguminosae family) protect dopamine neuronal degrada-
tion induced by MPTP and are also effective against neurotoxicities 
induced by 6-OHDA in PC12 cells [59]. Peroxynitrite (ONOO)-
toxicity is involved in neurodegenerative and inflammatory diseases 
such as PD. Alaternin isolated from this plant has potent ONOO-
scavenging activity and anti-inflammatory property, which makes it 
a suitable candidate for PD [60]. 
6. Chrysanthemum morifolium and Chrysanthemum indi-
cum  
 Chrysanthemum morifolium Ramat (Asteraceae family) can 
prevent the cytotoxicity and enhance cell viability in MPP+- in-
duced SH-SY5Y cells [61]. C. indicum L. is effective against 
MPP+ induced damage in SH-SY5Y cells [62]. The positive effects 
of these plants are not clear in in vivo studies. 
7. Cistanche deserticola, Cistanche tubulosa and Cistanche 
salsa 
 Cistanche deserticola, Cistanche tubulosa, and Cistanche salsa 
(Orobanchaceae) have protective activity on dopaminergic neurons 
of MPTP-induced PD in mice [63]. Echinacoside, isolated and puri-
fied from C. salsa protects the striatal monoamine neurotransmitters 
levels from diminution in 6-OHDA-induced lesion in rats. It also 
has neuroprotective, neurorescue and neurotrophic effects on 
MPTP-induced mice model of PD [64]. Acteoside, isolated from 
these plants, has neuroprotective effects against MPTP-induced 
mice model of PD and rotenone-induced damage of SH-SY5Y cells 
[65]. 
8. Cuscuta australis and Cuscuta chinensis 
 Cuscuta australis and Cuscuta chinensis (Convolvulaceae) are 
able to protect cells from apoptosis induced by MPP+ and salvianic 
acid in PC12 cells [66]. 
9. Ergot alkaloids 
 The ergot alkaloids have antiserotonin, dopaminomimetic, and 
antiadrenergic activities and have a broad spectrum of pharmacol-
ogical effects. Ergot alkaloids have sedative effect on the central 
nervous system and therapeutic effects against migraine, postpar-
tum haemorrhages, and mastopathy [67].  
 Most of the ergot alkaloids effects seem to result from their 
actions as partial agonists or antagonists at serotonergic, dopa-
minergic, adrenergic, and tryptaminergic receptors. These effects 
depend on the species, agent, tissue, dosage, and physiological con-
ditions. But, some of their actions are not compatible with this 
view. For example, while the agonistic effects of ergot are apparent 
at lower concentrations, the action of methysergide on cerebral 
blood vessels is opposite. In this regard, few rules on structure-
activity relationships have emerged for ergot alkaloids. Small amide 
derivatives of lysergic acid are relatively selective and potent an-
tagonists of 5-HT; however, the amino acid alkaloids mostly are 
less selective and reveal similar affinities as blocking agents at 
tryptaminergic and -adrenergic receptors [68]. 
 Most studies of ergot derivatives and PD have evaluated their 
effects on dopamine receptors. Ergoline ring has a structural simi-
larity to the endogenous monoamines which can explain the action 
of these compounds on serotonergic, dopaminergic, and adrenergic 
receptors. Pergolide, bromocriptine, and lisuride are presently 
available as oral ergot dopamine agonists. Bromocriptine, which 
has weak D1 receptor antagonistic property and D2 agonist effect, 
was the first ergoline recommended for PD. Both pergolide and 
bromocriptine are effective on relieving the symptoms of PD and 
reducing the on-off fluctuations of the disease. Pergolide which is 
the synthetic ergoline derivative has a mild D1 receptor agonistic 
effect and a long acting agonistic action at D2 dopamine receptors 
[67]. Two drugs possess similar efficacy and adverse effects. The 
efficacy of long acting bromocriptine is the same as the standard 
bromocriptine; however, the patients need fewer daily doses. 
Lisuride is a mild D1 receptor agonist and a potent postsynaptic 
striatal D2 receptor agonist. Its anti PD effect is equivalent to that of 
pergolide and bromocriptine [68].  
 Lisuride is a water-soluble drug and hence it can be used intra-
venously. For control of motor fluctuations of PD, lisuride is very 
effective when administered by continuous infusion. Its parenteral 
use might be complicated by incidence of psychiatric side effects, 
probably due to its serotonergic activities [67, 69]. 
10. Fraxinus rhynchophylla, F. chinensis, F. szaboana, F. siel-
boldiana 
 Fraxetin derived from these plants has antioxidant activity, 
reduces stress proteins, and is able to prevent the apoptotic death of  
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dopaminergic cells mediated by oxidative stress caused by rotenone 
in SH-SY5Y cells [70]. Liriodendrin and esculin, extracted from F. 
sielboldiana have anti-apoptotic effects on dopamine or MPP+-
induced cytotoxicity in SH-SY5Y cells [71, 72].  
11. Gastrodia elata 
 The ethanol extract of G. elata (Orchidaceae) possesses protec-
tive activity against MPP+-induced cytotoxicity on dopaminergic 
SH-SY5Y cells [73]. Vanillyl alcohol, a potent component of this 
plant, is able to protect dopaminergic MN9D cells through modulat-
ing the apoptotic process and antioxidant activity, against MPP+-
induced apoptosis. Therefore, it is a potential candidate for man-
agement of neurodegenerative complications such as PD [74]. 
12. Ginseng 
 Ginseng is a deciduous perennial shrub of any one of the 11 
species of slow-growing plants belonging to the genus Panax of the 
family Araliaceae. In fact, ginseng is a variety plants, mainly Ko-
rean or Asian ginseng (Panax ginseng), American ginseng (Panax 
quinquefolius), and Siberian ginseng (Eleutherococcus senticosus). 
Panax ginseng is an important plant which has long been used in 
traditional Chinese medicine for treatment of weakness and fatigue 
[75].  
 Ginseng grows in eastern Asia and North America, typically in 
cooler climates. Fleshy root of ginseng requires about 5 years of 
cultivation to reach maturity. Traditionally, the wild root was con-
sumed to strengthen, rejuvenate, and vitalize the entire body. Ko-
rean ginseng is more suitable for older people and men. Ginseng is 
believed to be an anti-aging herb and is a favorable herb due to low 
toxic effects on the body. Korean ginseng is thought to contain 
adaptogens which can return the body's system back to normal 
level. In this regard, ginsengs is used to balance the metabolism, 
increase energy levels, lower cholesterol, stimulate the immune 
system, reduce nervousness, and alleviate fatigue. Korean ginseng 
can stimulate the regeneration of damaged cells, promote detoxifi-
cation, and enhance the feeling of wellbeing through increasing 
oxygenation to cells [75, 76]. 
 Ginseng root has anti-aging, anti-cancer, and cardiovascular 
protective properties which are potentially due to its high level of 
antioxidant activity. There are 28 kinds of ginsenosides in Ameri-
can ginseng which can improve impairments in movement and loss 
of neurons in the brain. Ginseng has been shown to be effective in 
Huntington's disease or other neuropsychological disorders [75, 
77]. 
13. Gynostemma pentaphyllum 
 The whole plant ethanol extracts of Gynostemma pentaphyllum 
(Cucurbitaceae) have protective effects on 6-OHDA-induced rat 
model of PD [58]. Gypenosides extracted from G. pentaphyllum 
have neuroprotective activity against dopaminergic neurons in the 
substantia nigra of mice model of PD against MPP+-induced oxi-
dative injury [78, 79]. 
14. Hypericum perforatum 
 The methanol extract of Hypericum perforatum L. (Guttiferae) 
has protective effects against MPTP-induced PD in mice [80]. The 
extract of H. perforatum decreases oxidative stress and enhances 
gene expression of antioxidant enzymes on rotenone-exposed rats 
[81]. The whole extract and a flavonoid-rich extract from H. perfo-
ratum have also neuroprotective effects against trauma induced by 
H2O2 in PC12 cells. Hyperoside isolated from H. perforatum has 
been shown to protect the PC12 cells from the cytotoxicity induced 
by tert-butyl hydroperoxide and H2O2 [82],  
15. Ligusticum chuanxiong 
 Ligusticum chuanxiong Hort. (Umbelliferae) and tetramethyl-
pyrazine, one of its active components, are able to decrease the 
oxidative damage in PD induced by levodopa and improve the 
dopamine metabolic ratio in the rat striatum [83]. 
Tetramethylpyrazine is also able to protect dopaminergic neurons 
against MPTP-induced neurotoxicity in mice model of PD [84]. 
16. Mucuna pruriens 
 Mucuna pruriens is from the Fabaceae family and Faboidaceae 
subfamily. M. pruriens is an annual twinning plant in bushes and 
hedges. It is one of the popular medicinal plants indigenous to 
tropical countries like India [85].  
 It is useful in relieving inflammation, delirium, neuropathy, 
cephalagia, and general debility, nephropathy, dysmenorrhoea, 
amenorrhoea, ulcers, constipation, elephantiasis, consumption, 
helminthiasis, fever, and dropsy. The trichomes of pods contain 
serotonin and mucunain. The trichomes are used as anthelmintic. 
Seeds contain glutathione, gallic acid, levodopa (4-3, 4-dihydroxy 
phenylalanine), lecithin, prurenine, prurenidine, glycosides, nico-
tine, minerals, and dark brown viscous oil [85]. 
 In a double-blinded clinical and pharmacological study the 
plant was assessed for levodopa pharmacokinetics and clinical ef-
fects at two different doses in comparison with standard levodo-
pa/carbidopa. Thirty g M. pruriens preparation caused shorter 
latencies as compared to peak levodopa plasma concentration and 
considerably faster onset of effect. Mean time was 37 min (21%) 
longer with 30 g M. pruriens than with levodopa/carbidopa; peak 
levodopa plasma concentration was 110% higher and the area under 
the curve was 165.3% larger. There was no significant difference in 
tolerability or dyskinesia [86]. The longer action and rapid onset 
without increase in adverse effect suggest that M. pruriens seed 
powder with natural source of levodopa possibly has advantages 
over conventional levodopa preparations in treatment of PD. In this 
regard, evaluation of long term efficacy and tolerability in large 
controlled trials is required. 
 In an animal model of PD, M. pruriens (drug HP-200) was 
found to be better in comparison to synthetic levodopa. In this study 
administration of M. pruriens at doses of 2.5, 5.0 or 10.0 g/kg/day 
for 52 weeks significantly increased the dopamine content of the 
cortex. However, it had no significant effect on dopamine, 
levodopa, norepinephrine, serotonin or their metabolites in the ni-
grostriata. The ability of this plant to improve PD symptoms and 
failure to exert significant effect on dopamine metabolism in the 
striatonigral tract may suggest a levodopa enhancing effect or that 
its effect might be due to components other than levodopa [87]. 
17. Paeonia lactiflora Pall 
 In traditional Chinese medicine the dried root of Paeonia lacti-
flora (Ranunculaceae) and its principal bioactive component, Pae-
oniflorin, are widely used for the treatment of neurodegenerative 
disorders like PD. Paeoniflorin was also able to alleviate the neuro-
logical impairment induced by unilateral striatal 6-OHDA lesion in 
rat model and acidic damage through autophagic pathway [88, 89]. 
It also attenuates dopaminergic neurodegeneration and neuroin-
flammation in the mice model of PD by activation of adenosine 
receptors [90, 91]. Therefore, it could be a good candidate for the 
treatment of neurodegenerative diseases like PD. 
18. Polygala tenuifolia Willd and Polygala sibirica L. 
 The water extract from the root of Polygala tenuifolia and Poly-
gala sibirica L. (Polygalaceae) are able to prevent toxin-induced 
neuronal death in the PC12 cells caused by MPP+. Tenuigenin is an 
active component from P. tenuifolia and is able to protect the do-
paminergic neurons from inflammation-mediated damage induced 
by the lipopolysaccharides (LPS) or induced by 6-OHDA in SH-
SY5Y cells [92, 93]. 
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19. Polygonum cuspidatum Sieb 
 The dried root and rhizoma of Polygonum cuspidatum (Polygo-
naceae) and resveratrol, prepared from this plant are able to in-
crease degradation of -synucleins in expressing PC12 cell lines, to 
prevent neurotoxicity induced by human prion protein and to pro-
tect SH-SY5Y cells against rotenone-induced apoptosis. They are 
also able to modulate the markers of apoptotic death in dopaminer-
gic neurons against MPP+-induced oxidative stress. Resveratrol has 
protective effects on MPTP-induced neuron loss mediated by H2O2 
[94, 95] and on dopaminergic neurons from multiple insults in or-
ganotypic midbrain slice cultures. It potentiates cytochrome P450 2 
d22-mediated protection in paraquat- and maneb-induced PD by 
attenuating oxidative damage and DA depletion in 6-OHDA-
induced rat model [96]. Resveratrol is able to protect the neurons in 
nigral cells [97]. Pinostilbene, one of the resveratrol derivatives, has 
also protective activity against 6-OHDA-induced neurotoxicity in 
SH-SY5Y cells [98]. 
20. Psoralea corylifolia L. 
 The aqueous extract of Psoralea corylifolia (Leguminosae) has 
inhibitory effect on dopamine and noradrenaline transporters [99]. 
The bakuchiol, isolated from P. corylifolia, inhibits monoamine 
transporters and regulates monoaminergic functions. It has dopa-
minergic protective activity as well as antiparkinsonian-like effects 
[100]. 
21. Pueraria lobata Willd and Pueraria thomsonii Benth 
 Pueraria lobata and Pueraria thomsonii (Leguminosae), as 
well as their active component, puerarin, have protective effects 
against MPP+-induced apoptosis in SH-SY5Y cells and dopa-
minergic neurons against 6-OHDA neurotoxicity through upregula-
tion of glial cell line-derived neurotrophic factor. They also are able 
to inhibit the apoptosis in rat model of PD and regulate the effects 
of ubiquitin proteasome system [101, 102]. 
22. Rhodiola crenulata  
 Dried root and rhizoma of Rhodiola crenulata (Crassulaceae) 
and salidroside, one of its active components, are neuroprotective 
against MPP+-induced apoptosis in PC12 cells by activating 
PI3K/Akt and inhibiting the NO pathways [103]. 
23. Salvia miltiorrhiza Bge 
 The dried root and rhizoma of Salvia miltiorrhiza (Labiatae) 
and salvianolic acid A, salvianic acid A, and salvianolic acid B, 
derived from this plant, have protective effects against MPP+-
induced neurotoxicity. Salvianolic acid A, through increasing the 
stress tolerance, is able to protect neurons against H2O2-induced 
injury. Salvianolic acid B is able to protect PC12 cells against 
H2O2-induced cytotoxicity and SH-SY5Y cells against MPP- or 6-
OHDA-induced apoptosis [104-106]. 
24. Scutellaria baicalensis Georgi  
 Scutellaria baicalensis Georgi (Labiatae) and baicalein, one of 
its flavonoids, have neuroprotective activities in 6-OHDA induced 
PD. They also have protective effects against rotenone-induced 
neurotoxicity in isolated rat brain mitochondria and PC12 cells and 
protective effects against endoplasmic reticulum stress-induced 
apoptosis on HT22 murine hippocampal neuronal cells through 
substantial decrease in ROS production [107-109]. Baicalein pos-
sesses a neuroprotective effects against MPTP-induced neurotoxic-
ity in mice model of PD and reduces the inflammation-mediated 
degeneration of dopaminergic neurons by inhibition of microglial 
activation [110, 111]. 
25. Tripterygium wilfordii Hook 
 The extract of Tripterygium wilfordii (Celastraceae) protects the 
dopaminergic neurons from LPS-induced inflammatory damage 
[112]. Tripchlorolide and Triptolide, isolated from this plant, show 
neurotrophic and neuroprotective activities on dopaminergic neu-
rons against LPS or MPP+-induced damage through immunosup-
pressive therapy or inhibition of microglial activation. They also 
upregulate nerve growth factor synthesis in rat astrocyte cultures 
and enhance the adeno-virus-mediated gene transfer in mice stria-
tum [113, 114],  
26. Vicia faba beans  
 Vicia faba beans, also known as faba bean, fava bean, broad 
bean, horse bean, field bean, tic bean or bell bean is a member of 
Fabaceae (pea) family. Fava beans contain levodopa and are able to 
control the symptoms of PD, the same as drugs containing 
levodopa. Fava beans are thought to contain substances other than 
levodopa and are helpful for PD symptoms. The effect of fava bean 
lasts longer than that of levodopa medications [115].  
 The amount of levodopa in the bean is enough to be pharmaco-
logically active in PD. There are some reports indicating that the 
patients with PD would benefit from Vicia faba beans and in some 
cases the response to the beans might be better than conventional 
levodopa medications. At single dose the patients with PD having 
pronounced “on-off” motor oscillations benefited the effects of fava 
beans. The bean meal causes a longer response, which can be ex-
plained by higher plasma concentration. If both legumes and pods 
are ingested, the beans are relatively rich in protein. The beans 
could have potential advantages in reducing the off period [116].  
 Further research is needed to determine the efficacy of fava 
beans. In western countries, the fava beans are less known; there-
fore, their properties have been less understood, especially with 
regard to the levodopa content. It should be noted that various spe-
cies of fava plants have different amounts of levodopa and the pa-
tients cannot be sure to obtain the exact mount. High levels of 
levodopa can cause nausea and raw fava beans can cause an allergic 
reaction in some patients [110]. 
 Another consideration is the use of monoamine oxidase inhibi-
tor drugs, including phenelzine, tranylcypromine and isocarboxaz-
ide taken with pressor compounds (foods high in tyramine, dopa-
mine and phenylethylamine) which can cause a dangerous increase 
in blood pressure. The levodopa in fava or in medications can be 
converted to dopamine in the bloodstream. Favism which is an 
inherited disease in which the patients lack the enzyme glucose-6-
phosphate dehydrogenase (G6PD) should also be considered in 
patients who eat fava beans. These patients may develop hemolytic 
anemia. G6PD deficiency is seen mostly among African, Southeast 
Asian and Mediterranean populations [117]. 
DISCUSSION AND CONCLUSION  
 The pathogenesis of PD has not been yet fully understood. 
There are growing bodies of evidence indicating that oxidative 
stress and inflammation have important role in PD pathogenesis. 
This knowledge has enabled us to link th e  mitochondrial dys-
function an d  oxidative stress with the pathogenesis of PD. 
Substantia nigra is vulnerable to oxidative damage. The main fea-
ture of PD is the loss of dopaminergic neurons in the substantia 
nigra [26]. 
 Levodopa is the most effective medication for PD. It is con-
verted into dopamine and then is metabolized to dopamine quinone 
which acts as the major source of oxidative stress. It has been 
shown that dopamine causes selective toxicity to dopaminergic 
terminals proportional to the levels of dopamine oxidation and qui-
none-modified proteins Dopamine quinone modifies some proteins 
such as DJ-1, UCH-L1 and -synuclein which their dysfunctions 
have been shown to be linked to dopamine pathophysiology. 
Moreover, dopamine quinone- modified -synuclein is able to in-
hibit normal degradation of other proteins [118]. Furthermore, do-
pamine quinone species are able to modify the cellular molecules 
such as protein cysteinyl residues and GSH whose normal functions 
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are crucial for cell survival [119]. These changes and other events 
induced by dopamine quinone suggest that plant antioxidants may 
have protective effect against dopamine toxicity on dopaminergic 
neurons. 
 The preventive and treatment strategies that counteract oxida-
tive stress are encouraging in laboratory and animal models of PD. 
There are also studies suggesting agents that modulating mitochon-
drial function might be beneficial with regards to PD progression. 
However, the promising results of neuroprotective compounds in 
animal models have not been adequately tested in human clinical 
trials. It should be noted that oxidative stress and mitochondrial 
dysfunction are not specific to PD pathogenesis. There are a wide 
variety of other diseases such as cancer [120, 121], diabetes [122, 
123], atherosclerosis [124, 125], infections [126, 127] and toxic 
conditions [128, 129] which are complicated by oxidative stress and 
treated with antioxidants. Hence, modulation of oxidative stress can 
help to manage other oxidative stress-related conditions, as well.  
 Another remarkable point is that PD in humans starts long be-
fore its clinical symptoms manifestation. Therefore, preventive 
measures should be taken to reduce the risk of disease. Hence, the 
use of antioxidant compounds can be crucial. Antioxidants are a 
variety of compounds which can scavenge free radicals [130, 131]. 
However, not all antioxidants have been effective on management 
of PD and other oxidative stress-induced diseases [132, 133]. In 
comparison to herbal antioxidants, single antioxidants including 
vitamins C and E seem to be less effective on rescuing the cells 
from apoptosis [134]. Further studies are needed to understand the 
mechanisms underlying the different protective capacities of herbal 
antioxidants and single antioxidants such as vitamins C and E.  
 Furthermore, the plants presented in this paper, alongside anti-
oxidant activity, mostly have other compounds effective on PD. 
Hence, to what extent antioxidants are effective in prevention and 
treatment of PD should be investigated in clinical trials. If herbal 
antioxidants are effective per se, most plants with antioxidant activ-
ity [135-138] must contribute to treating PD, as well. 
CONFLICT OF INTEREST 
 The authors confirm that this article content has no conflict of 
interest. 
 ACKNOWLEDGEMENTS  
 The authors gratefully thank Research and Technology Deputy 
of Shahrekord University of Medical Sciences for supporting this 
study.  
CONTRIBUTIONS  
 AS, MB, HSh and MRK contributed to the collection of the 
data and preparation of first draft. AS and MRK edited the last ver-
sion. All read and confirmed the last version.
 
REFERENCES 
[1] Bagetta V, Sgobio C, Pendolino V, et al. Rebalance of striatal 
NMDA/AMPA receptor ratio underlies the reduced emergence of 
dyskinesia during D2-like dopamine agonist treatment in experi-
mental Parkinson’s disease. J Neurosci 2012; 32: 17921-31. 
[2] Gazewood JD, Richards DR, Clebak K. Parkinson disease: an update. 
Am Fam Physician 2013; 87: 267-73. 
[3] Rao SS, Hofmann LA, Shakil A. Parkinson’s disease: diagnosis 
and treatment. Am Fam Physician 2006; 74: 2046-54. 
[4] Blandini F.  Neural and immune mechanisms in the pathogene-
sis of Parkinson’s disease. J Neuroimmune Pharmacol 2013; 8: 
189-201. 
[5] Jafari S, Etminan M, Aminzadeh F, Samii A.  Head injury and 
risk of Parkinson disease: A systematic review and meta-
analysis. Mov Disord 2 0 1 3 ;  28:  1222-9. 
[6] Blandini F. Neural and immune mechanisms in the pathogenesis of 
Parkinson’s disease. J Neuroimmune Pharmacol 2013; 8, 189-201. 
[7] Li F, Zhu S, Wu C, Yan C, Liu Y, Shugan L. Neuroinammation 
and cell therapy for Parkinson’s disease. Front Biosci 2011; 3, 
1407-20. 
[8] Yan MH, Wang X, Zhu X. Mitochondrial defects and oxidative 
stress in Alzheimer disease and Parkinson disease. Free Radic Biol 
Med 2013; 62: 90-101. 
[9] Rabiei Z, Rafieian-Kopaei M. Neuroprotective effect of 
pretreatment with Lavandula officinalis ethanolic extract on blood-
brain barrier permeability in a rat stroke model. Asian Pacif J Trop 
Med 2014; 7: S421-S6. 
[10] Lindvall O. Developing dopaminergic cell therapy for 
Parkinson’s disease-give up or move forward? Mov Disord 
2013; 28: 268-73. 
[11] Scovassi IA. Parkinson’s disease: New insights. Biochem & Phar-
macol 2013; 2: 3. 
[12] Jayaraj RL. An Overview of Parkinson's Disease and Oxidative 
Stress: Herbal Scenario. Neuropathol Dis 2012; 1(2): 95-122.  
[13] Blandin F. Neural and immune mechanisms in the pathogenesis of 
Parkinson’s disease. J Neuroimmune Pharmacol 2013; 8: 189-201. 
[14] Beal MF. Mitochondria and neurodegeneration. Novartis Found 
Symp 2007; 287: 183-92. 
[15] Greenamyre JT, Hastings TG Biomedicine. Parkinson’s-divergent 
causes, convergent mechanisms. Science 2004; 304: 20-1122. 
[16] Hwang O. Role of Oxidative Stress in Parkinson’s disease. Exp Neuro-
biol 2013; 22(1): 11-7 
 [17] Rafieian-Kopaei M, Nasri H. Re: Erythropoietin ameliorates oxida-
tive stress and tissue injury following renal ischemia/reperfusion in 
rat kidney and lung. Med Princ Pract 2014; 23(1): 95. 
[18] Baradaran A, Nasri H, Rafieian-Kopaei M. Comment on: Anti-
oxidative stress activity of Stachys lavandulifolia aqueous extract 
in humans. Cell J 2013; 15(3): 272-3. 
[19] Baradaran A, Nasri H, Rafieian-Kopaei M. Oxidative stress and 
hypertension: Possibility of hypertension therapy with antioxidants. 
J Res Med Sci 2014; 19(4): 358-67. 
[20] Green DR, Kroemer G. The pathophysiology of mitochondrial cell 
death. Science 2004; 305: 626-9. 
[21] Weisskopf MG, O'reilly E, Chen H. Plasma urate and risk of 
Parkinson’s disease. Am J Epidemiol 2007; 166: 561-7. 
[22] Van Laar VS, Mishizen AJ, Cascio M, et al. Proteomic 
identification of dopamine-conjugated proteins from isolated rat 
brain mitochondria and SH-SY5Y cells. Neurobiol Dis 2009; 34: 
487-500. 
[23] Conway KA, Rochet JC, Bieganski RM, Lansbury PT. Kinetic 
stabilization of the alpha-synuclein protofibril by a dopamine-
alpha-synuclein adduct. Science 2001; 294: 1346-9. 
[24] Qu W, Fan L, Kim YC, Kaempferol derivatives prevent oxidative 
stress-induced cell death in a DJ-1-dependent manner. J Pharmacol 
Sci 2009; 110: 191-200. 
[25] Zafar KS, Inayat-Hussain SH, Ross D. A comparative study of 
proteasomal inhibition and apoptosis induced in N27 
mesencephalic cells by dopamine and MG132. J Neurochem 2007; 
102: 913-21. 
[26] Zecca L, Wilms H, Geick S, et al. Human neuromelanin induces 
neuro- inflammation and neurodegeneration in the rat substantia 
nigra: implications for Parkinson’s disease. Acta Neuropathol 
2008; 116: 47-55. 
[27] R abinovic AD, Lewis DA, Hastings TG. Role of oxidative 
changes in the degeneration of dopamine termi- nals after injection 
of neurotoxic le vels of dopamine. Neuroscience 2000; 101: 67-76. 
[28] Beal MF. Mitochondrial dysfunction and oxidative damage in 
Alzheimer’s and Parkinson’s diseases and coenzyme Q10 as a po-
tential treatment. J Bioenerg Biomembr 2004; 36: 381-6 
[29] Shults CW. Effects of coenzyme Q10 in early Parkinson disease: 
evidence of slowing of the functional decline. Arch Neurol 2002; 
59: 1541-50. 
[30] Lu KT. Neuroprotective effects of resveratrol on MPTP-induced 
neuron loss mediated by free radical scavenging. J Agric Food Chem 
2008; 56: 6910-3. 
[31] Shirzad H, Taji F, Rafieian-Kopaei M. Correlation between anti-
oxidant activity of garlic extracts and WEHI-164 fibrosarcoma tu-
mor growth in BALB/c mice. J Med Food 2011; 14(9): 969-74.  
[32] Shirzad H, Shahrani M, Rafieian-Kopaei M. Comparison of mor-
phine and tramadol effects on phagocytic activity of mice perito-
neal phagocytes in vivo. Int Immunopharmacol 2009; 9(7-8): 968-
70.  
Oxidative Stress, Antioxidants, Parkinson’s Disease Current Pharmaceutical Design, 2016, Vol. 22, No. 00 7 
[33] Bahmani M, Zargaran A, Rafieian-Kopaei M, Saki M. Ethnobo-
tanical study of medicinal plants used in the management of diabe-
tes mellitus in the Urmia, Northwest Iran. Asian Pac J Trop Med 
2014; 7(Suppl 1): 348-54.  
[34] Mirhoseini M, Baradaran A, Rafieian-Kopaei M. Medicinal plants, 
diabetes mellitus and urgent needs. J Herbmed Pharmacol 2013; 
2(2): 53-4.  
[35] Rafieian-Kopaei M, Shahinfard N, Rouhi-Boroujeni H, et al. Ef-
fects of Ferulago angulata extract on serum lipids and lipid peroxi-
dation. Evid-Base Compl Alternat Med 2014 (2014), Article 
ID 680856, 4 pages http: //dx.doi.org/10.1155/2014/680856. 
[36] Mirhosseini M, Baradaran A, Rafieian-Kopaei M. Anethum 
graveolens and hyperlipidemia: A randomized clinical trial. J Res 
Med Sci 2014; 19: 758-61. 
[37] Bahmani M, Zargaran A, Rafieian-Kopaei M. Identification of 
medicinal plants of Urmia for treatment of gastrointestinal disor-
ders. Rev Bras Farmacogn 2014; 24: 468-48. 
[38] Bahmani M, Rafieian-Kopaei M, Hassanzadazar H, Saki K, 
Karamati SA, Delfan B. A review on most important herbal and 
synthetic antihelmintic drugs. Asian Pac J Trop Med 2014; 7(Suppl 
1): 29-33. 
[39] Saki K, Bahmani M, Rafieian-Kopaei M. The effect of most impor-
tant medicinal plants on two important psychiatric disorders (anxi-
ety and depression)-a review. Asian Pac J Trop Med 2014; 7(Suppl 
1): 34-42. 
[40] Bahmani M, Shirzad HA, Majlesi M, Shahinfard N, Rafieian-
Kopaei M. A review study on analgesic applications of Iranian me-
dicinal plants. Asian Pac J Trop Med 2014; 7(Suppl 1): 43-53. 
[41] Henchcliffe C,  Flint-Beal M. Mitochondrial biology and oxidative stress 
in Parkinson disease pathogenesis. Nature Neurol 2009. doi: 
10.1038/ncpneuro0924. 
[42] Rabiei Z, Rafieian-kopaei M, Heidarian E, Saghaei E, Mokhtari S. 
Effects of zizyphus jujube extract on memory and learning 
impairment induced by bilateral electric lesions of the nucleus 
basalis of meynert in rat. Neurochem Res 2014; 39(2): 353-60. 
[43] Delfan B, Bahmani M, Hassanzadazar H, Saki K, Rafieian-Kopaei 
M. Identification of medicinal plants affecting on headaches and 
migraines in Lorestan Province, West of Iran. Asian Pac J Trop 
Med 2014; 7(Suppl 1): 376-9. 
[44] Asadi-Samani M, Bahmani M, Rafieian-Kopaei M. The chemical 
composition, botanical characteristic and biological activities of 
Borago officinalis: a review. Asian Pac J Trop Med 2014; 7(Suppl 
1): 22-8. 
[45] Liu SM, Li XZ, Huo Y, Lu F. Protective effect of extract of Acan-
thopanax senticosus Harms on dopaminergic neurons in Parkin-
son's disease mice. Phytomedicine 2012; 19: 631-8. 
[46] Lahaie-Collins V, Bournival J, Plouffe M, Carange J, Martinoli 
MG. Sesamin modulates tyrosine hydroxylase, superoxide dismu-
tase, catalase, inducible NO synthase and interleukin-6 expression 
in dopaminergic cells under MPP+-induced oxidative stress. Oxid 
Med Cell Longev 2008; 1: 54-62. 
[47] Asgari S, Setorki M, Rafieian-kopaei M, et al. Postprandial hypol-
ipidemic and hypoglycemic effects of Allium hertifolium and 
Sesamum indicum on hypercholesterolemic rabbits. Afr J Pharm 
Pharmacol.2012; 6(15): 1131 -5. 
[48] Zhang ZJ, Cheang LC, Wang MW, et al. Ethanolic extract of fruc-
tus Alpinia oxyphylla protects against 6-hydroxydopamineinduced 
damage of PC12 cells in vitro and dopaminergic neurons in zebraf-
ish. Cell Mol Neurobiol 2012; 32: 27-40. 
[49] An LJ, Guan S, Shi GF, Bao YM, Duan YL, Jiang B. Protocate-
chuic acid from Alpinia oxyphylla against MPP+-induced neuro-
toxicity in PC12 cells. Food Chem Toxicol 2006; 44: 436-43. 
[50] Zhang ZG, Wu L, Wang JL, et al. Astragaloside IV prevents 
MPP(+)-induced SH-SY5Y cell death via the inhibition of Bax-
mediated pathways and ROS production. Mol Cell Biochem 2012; 
364: 209-16. 
 [51] LI WX, Sun SG, Yuan H, Wang HT, Zhang YB, Sun BL. Time 
dependency of astragalus polysaccharides against systemic injury 
of free radical in astrocyte culture medium. Chin J Clin Rehabil 
2006; 10: 56-61. 
[52] Tanaka K, Miyake Y, Fukushima W, et al. Intake of Japanese and 
Chinese teas reduces risk of Parkinson's disease. Parkinsonism Re-
lat Disord 2011; 17: 446-50. 
[53] Guo S, Yan J, Yang T, Yang X, Bezard E, Zhao B. Protective 
effects of green tea polyphenols in the 6-OHDA rat model of Park-
inson's disease through inhibition of ROS-NO pathway. Biol Psy-
chiatry 2007; 62: 1353-62. 
[54] Li R, Peng N, Li XP, Le WD. (-)-Epigallocatechin gallate regulates 
dopamine transporter internalization via protein kinase C-
dependent pathway. Brain Res 2006; 1097: 85-9. 
[55] Choi JY, Park CS, Kim DJ, et al. Prevention of nitric oxide-
mediated 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine- induced 
Parkinson's disease in mice by tea phenolic epigallocatechin 3-
gallate. Neurotoxicology 2002; 23: 367-74. 
[56] Kim JS, Kim JM, O JJ, Jeon BS. Inhibition of inducible nitric oxide 
synthase expression and cell death by (-)-epigallocatechin-3-
gallate, a green tea catechin, in the 1-methyl-4-phenyl-1, 2, 3, 6-
tetrahydropyridine mouse model of Parkinson's disease. J Clin 
Neurosci 2010; 17: 1165-8. 
[57] Asadi SY, Parsaei P, Karimi M, et al. Effect of green tea (Camellia 
sinensis) extract on healing process of surgical wounds in rat. Int J 
Surg 2013; 11(4): 332-7. 
[58] Asadi Y, Karimi M, Parsaei P, et al. Effects of Camellia sinensis 
Ethanolic Extract on Histometric and Histopathological Healing 
Process of Burn Wound in Rat. Middle-East J Sci Res 2013; 13 (1): 
14-9. 
[59] Ju MS, Kim HG, Choi JG, et al. Cassiae semen, a seed of Cassia 
obtusifolia, has neuroprotective effects in Parkinson's disease mod-
els. Food Chem Toxicol 2010; 48: 2037-44. 
 [60] Shin BY, Kim DH, Hyun SK, et al. Alaternin attenuates delayed 
neuronal cell death induced by transient cerebral hypoperfusion in 
mice. Food Chem Toxicol 2010; 48: 1528-36. 
[61] Kim IS, Koppula S, Park PJ, et al. Chrysanthemum morifolium 
Ramat (CM) extract protects human neuroblastoma SH-SY5Y cells 
against MPP+-induced cytotoxicity. J Ethnopharmacol 2009; 126: 
447-54. 
[62] Kim IS, Ko HM, Koppula S, Kim BW, Choi DK. Protective effect 
of Chrysanthemum indicum Linne against 1-methyl-4-
phenylpridinium ion and lipopolysaccharide-induced cytotoxicity 
in cellular model of Parkinson's disease. Food Chem Toxicol 2011; 
49: 963-73. 
[63] Li WW, Yang R, Cai DF. Protective effects of Cistanche total 
glycosides on dopaminergic neuron in substantia nigra of model 
mice of Parkinson's disease. Zhongguo Zhong Xi Yi Jie He Za Zhi 
2008; 28: 248-51. 
[64] Zhao Q, Gao J, Li W, Cai D. Neurotrophic and neurorescue effects 
of echinacoside in the subacute MPTP mouse model of Parkinson's 
disease. Brain Res 2010; 1346: 224-36. 
[65] Gao Y, Pu XP. Neuroprotective effect of acteoside against rote-
noneinduced damage of SH-SY5Y cells and its possible mecha-
nism. Chin Pharmacol Bull 2007; 23: 161-5. 
[66] Li ZG, Jiang B, Bao YM, An LJ. Protection of Semen Cuscuta 
extracts from apoptosis PC12 cell of induced by1-methyl-4-
phenylpyridinium. Chin Tradit Pat Med 2006; 28: 219-21. 
[67] Langley D. Exploiting the fungi: novel leads to new medicines, 
Mycologist 1998; 11: 165-6. 
[68] Komarova EL, Tolkachev ON. The chemistry of peptide ergot 
alkaloids, Pharmaceut Chem J 2001; 35: 504-6. 
[69] Robinson SL, Panaccione DG. Heterologous expression of lysergic 
acid and novel ergot alkaloids in aspergillus fumigatus. Appl. 
Environ. Microbiol. October 2014; 80(20): 6465-72. 
[70] Molina-Jimenez MF, Sanchez-Reus MI, Andres D, Cascales M, 
Benedi J. Neuroprotective effect of fraxetin and myricetin against 
rotenone-induced apoptosis in neuroblastoma cells. Brain Res 
2004; 1009: 9-16. 
[71] Zhao DL, Zou LB, Lin S, Shi JG, Zhu HB. Anti-apoptotic effect of 
esculin on dopamine-induced cytotoxicity in the human neuroblas-
toma SH-SY5Y cell line. Neuropharmacology 2007; 53: 724-32. 
[72] Zhao DL, Shi L, Zhai KG, et al. Esculin, an extract from Fraxinus 
sielboldiana blume, protects SH-SY5Y cells fromMPP+-induced 
cytotoxicity. Acad J PLA Postgrad Med Sch 2008; 29: 112-4. 
[73] An H, KimIS, Koppula S, et al. Protective effects of Gastrodia 
elata Blume on MPP+-induced cytotoxicity in human dopaminergic 
SH-SY5Y cells. J Ethnopharmacol 2010; 130: 290-8. 
[74] Kim IS, Choi DK, Jung HJ. Neuroprotective effects of vanillyl 
alcohol in Gastrodia elata Blume through suppression of oxidative 
stress and anti-apoptotic activity in toxin-induced dopaminergic 
MN9D cells. Molecules 2011; 16: 5349-61. 
[75] In-Ho B, Seung-Ho SO. The world ginseng market and the 
ginseng. J Ginseng Res. 2013; 37(1): 1-6. 
8 Current Pharmaceutical Design, 2016, Vol. 22, No. 00 Sarrafchi et al. 
[76] Mahady GB, Gyllenhall C, Fong HH, Farnsworth NR. Ginsengs: a 
review of safety and efficacy. Nutr Clin Care 2000; 3: 90-101. 
[77] Kaneko H. Proof of the mysterious efficacy of ginseng: basic and 
clinical trials: clinical effects of medical ginseng, Korean red gin-
seng: specifically, its anti-stress action for prevention of disease. J 
Pharmacol Sci 2004; 95(2): 158-62. 
[78] Wang P, Niu L, Guo XD, et al. Gypenosides protects dopaminergic 
neurons in primary culture against MPP(+)-induced oxidative in-
jury. Brain Res Bull 2010; 83: 266-71. 
[79] Wang P, Niu L, Gao L, et al. Neuroprotective effect of gypenosides 
against oxidative injury in the substantia nigra of a mouse model of 
Parkinson's disease. J Int Med Res 2010; 38: 1084-92. 
[80] Mohanasundari M, Sabesan M. Modulating effect of Hypericum 
perforatum extract on astrocytes in MPTP induced Parkinson's dis-
ease in mice. Eur Rev Med Pharmacol Sci 2007; 11: 17-20. 
[81] Lu YH, Du CB, Liu JW, Hong W, Wei DZ. Neuroprotective effects 
of Hypericum perforatum on trauma induced by hydrogen peroxide 
in PC12 cells. Am J Chin Med 2004; 32: 397-405. 
[82] Zou YP, Lu YH, Wei DZ. Protective effects of a flavonoid-rich 
extract of Hypericum perforatum L.against hydrogen peroxide in-
duced apoptosis in PC12 cells. Phytother Res 2010; 24(Suppl 1): 
S6-S10. 
[83] Wang DQ, Wang W, Jing FC, Zhao JN. Effects of 
tetramethylpyrazine on the extracellular DA, its metabolites and 
hydroxyl radical in striatum of PD rats treated by L-DOPA. Chin 
Pharm J 2007; 42: 28-32. 
[84] Du J, Shan LC, Zhang GX, Wang YQ. Effect of TMP on dopa-
minergic neuron injury induced by MPTP in vivo and vitro. Lishiz-
hen Med Mater Med Res 2011; 22: 1564-5. 
[85] Verma DM, Balakrishnan NP, . Dixit RD. Flora of Madhya 
Pradesh. Botanical Survey of India.. Lucknow, India. 1993. 
[86] Pruriens M. Research Update. Mucuna pruriens in Parkinson's 
disease: a double blind clinical and pharmacological study. J Neu-
rol Neurosurg Psychiatry 2004; 75(12): 1672-7. 
[87] Manyam BV, Dhanasekaran M, Hare TA. Effect of antiparkinson 
drug HP-200 (Mucuna pruriens) on the central monoaminergic neu-
rotransmitters. Phytother Res 2004; 18(2): 97-101. 
[88] Liu DZ, Zhu J, Jin DZ, et al. Behavioral recovery following sub-
chronic paeoniflorin administration in the striatal 6-OHDA lesion 
rodent model of Parkinson's disease. J Ethnopharmacol 2007; 112: 
327-32. 
[89] Cao BY, Yang YP, Luo WF, et al. Paeoniflorin, a potent natural 
compound, protects PC12 cells from MPP+ and acidic damage via 
autophagic pathway. J Ethnopharmacol 2010; 131: 122-9. 
[90] Liu HQ, Zhang WY, Luo XT, Ye Y, Zhu XZ. Paeoniflorin attenu-
ates neuroinflammation and dopaminergic neurodegeneration in the 
MPTP model of Parkinson's disease by activation of adenosine A1 
receptor. Br J Pharmacol 2006; 148: 314-25. 
[91] Choi JG, Kim HG, Kim MC, et al. Polygalae radix inhibits toxin-
induced neuronal death in the Parkinson's disease models. J Ethno-
pharmacol 2011; 134: 414-21. 
[92] Liang Z, Shi F, Wang Y, Lu L, Zhang Z, Wang X. Neuroprotective 
effects of tenuigenin in a SH-SY5Y cell model with 6-OHDA-
induced injury. Neurosci Lett 2011; 497: 104-9. 
[93] Yuan HL, Li B, Xu J, et al. Tenuigenin protects dopaminergic 
neurons from inflammation-mediated damage induced by the 
lipopolysaccharide. CNS Neurosci Ther 2012; 18: 584-90. 
[94] Jeong JK, Moon MH, Bae BC, et al. Autophagy induced by res-
veratrol prevents human prion protein-mediated neurotoxicity. 
Neurosci Res 2012; 73: 99-105. 
[95] Bournival J, Quessy P, Martinoli MG. Protective effects of resvera-
trol and quercetin against MPP+-induced oxidative stress act by 
modulating markers of apoptotic death in dopaminergic neurons. 
Cell Mol Neurobiol 2009; 29: 1169-80. 
[96] Srivastava G, Dixit A, Yadav S, Patel DK, Prakash O, Singh MP. 
Resveratrol potentiates cytochrome P450 2 d22-mediated neuropro-
tection in maneb- and paraquat-induced Parkinsonism in the 
mouse. Free Radic Biol Med 2012; 52: 1294-306. 
[97] Jin F, Wu Q, Lu YF, Gong QH, Shi JS. Neuroprotective effect of 
resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur J 
Pharmacol 2008; 600: 78-82. 
[98] Chao J, Li H, Cheng KW, Yu MS, Chang RC, Wang M. Protective 
effects of pinostilbene, a resveratrol methylated derivative, against 
6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells. J 
Nutr Biochem 2010; 21: 482-9. 
[99] hao G, Li S, Qin GW, Fei J, Guo LH. Inhibitive effects of Fructus 
Psoraleae extract on dopamine transporter and noradrenaline trans-
porter. J Ethnopharmacol 2007; 112: 498-506. 
[100] Zhao G, Zang SY, Zheng XW, Zhang XH, Guo LH. Bakuchiol 
analogs inhibit monoamine transporters and regulate monoaminer-
gic functions. Biochem Pharmacol 2008; 75: 1835-47. 
[101] Zhu G, Wang X, Wu S, Li Q. Involvement of activation of 
PI3K/Akt pathway in the protective effects of puerarin against 
MPP+-induced human neuroblastoma SH-SY5Y cell death. Neuro-
chem Int 2012; 60: 400-8. 
[102] Zhu G, Wang X, Chen Y, et al. Puerarin protects dopaminergic 
neurons against 6-hydroxydopamine neurotoxicity via inhibiting 
apoptosis and upregulating glial cell line-derived neurotrophic fac-
tor in a rat model of Parkinson's disease. Planta Med 2010; 76: 
1820-6. 
[103] Li X, Ye X, Sun X, et al. Salidroside protects against MPP(+)-
induced apoptosis in PC12 cells by inhibiting the NO pathway. 
Brain Res 2011; 1382: 9-18. 
[104] Wang XJ, Xu JX. Salvianic acid A protects human neuroblastoma 
SH-SY5Y cells against MPP+ induced cytotoxicity. Neurosci Res 
2005; 51: 129-38. 
[105] Zhang HA, Gao M, Zhang L, et al. Salvianolic acid A protects 
human SH-SY5Y neuroblastoma cells against H2O2 induced injury 
by increasing stress tolerance ability. Biochem Biophys Res Com-
mun 2012; 421: 479-83. 
[106] Tian LL, Wang XJ, Sun YN, et al. Salvianolic acid B, an antioxi-
dant from Salvia miltiorrhiza, prevents 6hydroxydopamine induced 
apoptosis in SH-SY5Y cells. Int J Biochem Cell Biol 2008; 40: 
409-22. 
[107] Mu X, He G, Cheng Y, Li X, Xu B, Du G. Baicalein exerts neuro-
protective effects in 6 hydroxydopamine-induced experimental 
Parkinsonism in vivo and in vitro. Pharmacol Biochem Behav 
2009; 92: 642-8. 
[108] Li XX, He GR, Mu X, et al. Protective effects of baicalein against 
rotenone-induced neurotoxicity in PC12 cells and isolated rat brain 
mitochondria. Eur J Pharmacol 2012; 674: 227-33. 
[109] Choi JH, Choi AY, Yoon H, et al. Baicalein protects HT22 murine 
hippocampal neuronal cells against endoplasmic reticulum stress-
induced apoptosis through inhibition of reactive oxygen species 
production and CHOP induction. Exp Mol Med 2010; 42: 811-22. 
[110] Mu X, He GR, Yuan X, Li XX, Du GH. Baicalein protects the 
brain against neuron impairments induced by MPTP in C57BL/6 
mice. Pharmacol Biochem Behav 2011; 98: 286-91. 
[111] Li FQ, Wang T, Pei Z, Liu B, Hong JS. Inhibition of microglial 
activation by the herbal flavonoid baicalein attenuates inflamma-
tion-mediated degeneration of dopaminergic neurons. J Neural 
Transm 2005; 112: 331-47. 
[112] Liu Y, Chen HL, Yang G. Extract of Tripterygium wilfordii Hook 
F protect dopaminergic neurons against lipopolysaccharide-induced 
inflammatory damage. Am J Chin Med 2010; 38: 801-14. 
[113] Li FQ, Cheng XX, Liang XB, et al. Neurotrophic and neuroprotec-
tive effects of tripchlorolide, an extract of Chinese herb Triptery-
gium wilfordii Hook F, on dopaminergic neurons. Exp Neurol 
2003; 179: 28-37. 
[114] Xue B, Jiao J, Zhang L, et al. Triptolide upregulates NGF synthesis 
in rat astrocyte cultures. Neurochem Res 2007; 32: 1113-9.  
[115] Rabey JM, Vered Y, Shabtai H, Graff E, Harsat A, Korczyn AD. 
Broad bean (Vicia faba) consumption and Parkinson's disease. Adv 
Neurol 1993; 60: 681-4. 
[116] Baginsky C, Peña-Neira A, Cáceres A. et al. Phenolic compound 
composition in immature seeds of fava bean (Vicia faba L.) varie-
ties cultivated in Chile. J Food Compost Anal 2013; 31(1): 1-6. 
[117] Essa MM, Braidy N, Bridge W. et al. Review of natural products 
on parkinson’s disease pathology. The J Aging Res Clin Pract 
2014; 3(1): 1-8. 
[118] Martinez-Vicente M, Talloczy Z, Kaushik S, et al. Dopamine- modi-
fied a lpha-synuclein blocks chaperone-med iated autophagy. J Clin 
Invest 2008; 118: 777-88. 
[119] Conway KA, Rochet JC, Bieganski RM, Lansbury PT. Kinetic stabilization 
of the alpha-synuclein protofibril by a dopamine-alpha-synuclein ad-
duct. Science 2001; 294: 1346-9. 
[120] Ghasemi-Pirbaluti M, Pourgheysari B, Shirzad H, et al. Effect of 
Epigallocatechin-3-gallate (EGCG) on cell proliferation inhibition 
and apoptosis induction in lymphoblastic leukemia cell line. J 
Herbmed Pharmacol 2015; 4(2): 65-8. 
Oxidative Stress, Antioxidants, Parkinson’s Disease Current Pharmaceutical Design, 2016, Vol. 22, No. 00 9 
[121] Shirzad H, Kiani M, Shirzad M. Impacts of tomato extract on the 
mice fibrosarcoma cells. J Herbmed Pharmacol 2013; 2(1): 13-6. 
[122] Behradmanesh S, Horestani MK, Baradaran A, Nasri H. Associa-
tion of serum uric acid with proteinuria in type 2 diabetic patients. J 
Res Med Sci 2013; 18: 44-6. 
[123] Rafieian-Kopaei M, Nasri H. The Ameliorative effect of Zingiber 
officinale in diabetic nephropathy. Iran Red Crescent Med J 2014 
May; 16(5): e11324. 
[124] Asgary S, Kelishadi R, Rafieian-Kopaei M, Najafi S, Najafi M, 
Sahebkar A. Investigation of the lipid-modifying and antiinflamma-
tory effects of Cornus mas L. supplementation on dyslipidemic 
children and adolescents. Pediatr Cardiol 2013; 34(7): 1729-35.  
[125] Asgary S, Rafieian-Kopaei M, Shamsi F, Najafi S, Sahebkar A. 
Biochemical and histopathological study of the anti-hyperglycemic 
and anti-hyperlipidemic effects of cornelian cherry (Cornus mas L.) 
in alloxan-induced diabetic rats. J Complement Integr Med 2014; 
11(2): 63-9.  
[126] Rahimian G, Sanei MH, Shirzad H, et al. Virulence factors of 
Helicobacter pylori vacA increase markedly gastric mucosal TGF-
1 mRNA expression in gastritis patients. Microb Pathog 2014 
Feb-Mar; 67-68: 1-7. doi: 10.1016/j.micpath.2013.12.006. Epub 
2014 Jan 21. 
[127] Bahmani M, Rafieian-Kopaei M, Hassanzadazar H, Saki K, 
Karamati SA, Delfan B. A review on most important herbal and 
synthetic antihelmintic drugs. Asian Pac J Trop Med 2014; 7(Suppl 
1): 29-33. 
[128] Taghikhani A, Afrough H, Ansari-Samani R, Shahinfard N, 
Rafieian-Kopaei M. Assessing the toxic effects of hydroalcoholic 
extract of Stachys lavandulifolia Vahl on rat's liver. Bratisl Lek 
Listy 2014; 115(3): 121-4. 
[129] Heidarian E, Rafieian-Kopaei M. Protective effect of artichoke 
(Cynara scolymus) leaf extract against lead toxicity in rat. Pharm 
Biol 2013; 51(9): 1104-9.  
[130] Nasri H, Rafieian-Kopaei M. Protective effects of herbal antioxi-
dants on diabetic kidney disease. J Res Med Sci 2014; 19(1): 82-3. 
[131] Baradaran A, Nasri H, Nematbakhsh M, Rafieian-Kopaei M. Anti-
oxidant activity and preventive effect of aqueous leaf extract of 
Aloe Vera on gentamicin-induced nephrotoxicity in male Wistar 
rats. Clin Ter 2014; 165(1): 7-11. 
[132] Nasri H, Rafieian-Kopaei M. Medicinal plants and antioxidants: 
Why they are not always beneficial? Iranian Journal of Public 
Health 2014; 43(2): 255-7.  
[133] Rafieian-Kopaei M, Baradaran A, Rafieian M. Oxidative stress and 
the paradoxical effects of antioxidants. J Res Med Sci 2013; 18(7): 
628. 
[134] Offen D, Ziv I, Sternin H, Melamed E, Hochman A. Prevention of 
dopamine-induced cell death by thiol antioxidants: possible impli-
cations for treatment of Parkinson's disease. Experimental Neurol-
ogy 1996; 141(1): 32-9. 
[135] Asadbeigi M, Mohammadi T, Rafieian-Kopaei M, Saki K, Bah-
mani M, Delfan B. Traditional effects of medicinal plants in the 
treatment of respiratory diseases and disorders: an ethnobotanical 
study in the Urmia. Asian Pac J Trop Med 2014; 7(Suppl 1): S364-
8. 
[136] Parsaei P, Karimi M, Asadi SY, Rafieian-Kopaei M. Bioactive 
components and preventive effect of green tea (Camellia sinensis) 
extract on postlaparotomy intra-abdominal adhesion in rats. Int J 
Surg 2013; http: //dx.doi.org/10.1016/j.ijsu.2013.08.014. 
[137] Delfan B, Bahmani M, Rafieian-Kopaei M, Delfan M, Saki K. A 
review study on ethnobotanical study of medicinal plants used in 
relief of toothache in Lorestan Province, Iran. Asian Pac J Trop Dis 
2014; 4(Suppl 2): 879-84. 
[138] Bahmani M, Saki K, Rafieian-Kopaei M, Karamati SA, Eftekhari 
Z, Jelodari M. The most common herbal medicines affecting Sar-
comastigophora branches: a review study. Asian Pac J Trop Med 
2014; 7(Suppl 1): 14-21 
 
 
Received: August 1, 2015  Accepted: November 11, 2015 
View publication stats
